Infinitopes 🇬🇧
UK drug discovery company with a programme in Phase 2 clinical trials. Kindred Capital took part in the round.
About Infinitopes
Infinitopes develops a Precision Immunomics™ platform that utilizes immunopeptidomics, advanced liquid chromatography-mass spectrometry (LC/MS), and artificial intelligence/machine learning (AI/ML) to identify tumor-specific antigens for cancer vaccines. Their proprietary viral vectors are engineered for efficient CD8 T-cell protection, enabling scalable and cost-effective manufacturing of off-the-shelf vaccines aimed at early-stage, treatment-naïve patients.
Infinitopes is a UK-based company founded in 2021, now around 30 people. FundFinder classes it as Health & Bio.
Founded by Senthil Chinnakannan (Co-Founder; previously Conception X, Piramal Group; Indian Institute of Science (IISc)), Lian Ni Lee (Co-founder & VP Preclinical; repeat founder; previously Stealth Company (Lian Ni Lee); UCL).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Undisclosed · Jan 2026
Kindred Capital- Kindred Capital — Kindred Capital is a London-based early-stage VC that practises "equitable venture": every founder it backs becomes a co-owner of the fund. · cheques £500k – £1.5M